Healthy high growth potential

Results

1503

Analysts expect these companies to experience strong growth in earnings over the next 3 years. They also meet criteria around being in an acceptable financial position.

1503 companies

CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv YieldIndustry
AV1
AU$0.0813.8%-29.6%AU$75.1mAU$0.177.9108.4%n/aSoftware
MDGL
US$550.25-2.7%59.5%US$12.4bUS$678.7111.259.2%n/aPharmaceuticals & Biotech
CDR
zł231.90-1.1%-12.6%zł23.1bzł235.1344.929.7%0.4%Media
AGP
€7.411.6%-4.5%€135.1m€8.5727.239.1%n/aCapital Goods
WAYS
SEK 38.501.6%-7.7%SEK 337.6mSEK 58.00204.978.5%0%Tech
KEBNI B
SEK 1.082.9%-53.6%SEK 295.7mSEK 1.252.690.9%n/aTech
CORT
US$89.57-3.6%23.0%US$9.7bUS$97.50206.047.8%n/aPharmaceuticals & Biotech
MOD
US$231.96-1.6%154.1%US$12.2bUS$340.86101.449.2%n/aCapital Goods
AXSM
US$237.53-3.3%113.4%US$12.1bUS$280.3917.357.0%n/aPharmaceuticals & Biotech
001389
CN¥195.636.7%194.8%CN¥89.5bCN¥248.6779.232.2%0.3%Tech
600183
CN¥146.99-6.6%292.4%CN¥370.3bCN¥137.0890.927.9%1.1%Tech
MX1
AU$0.0352.9%-28.6%AU$25.4mAU$0.151.5105.5%n/aHealthcare
688192
CN¥64.0038.3%-4.3%CN¥31.4bCN¥83.0033.3105.9%n/aPharmaceuticals & Biotech
4417
JP¥4,450.0013.4%57.8%JP¥65.5bJP¥4,500.0044.924.1%1.1%Software
9218
JP¥748.002.9%14.5%JP¥7.7bn/a33.028.9%1.3%Healthcare
NVDA
US$212.504.1%24.0%US$5.1tUS$301.9732.222.3%0.5%Semiconductors
RHM
€976.10-7.8%-46.3%€45.4b€1,697.8543.330.6%1.2%Capital Goods
LITE
US$752.006.3%654.8%US$63.4bUS$1,103.49133.356.3%n/aTech
CRDO
US$226.74-12.4%124.1%US$44.0bUS$271.9289.527.7%n/aSemiconductors
FWRY
ج.م18.63-3.9%51.6%ج.م63.5bج.م22.4523.827.3%n/aDiversified Financials
2368
NT$1,010.00-6.0%216.1%NT$518.0bNT$1,485.0045.038.2%1.0%Tech
456A
JP¥1,555.00-4.9%n/aJP¥141.4bn/a44.023.4%n/aRetail
7685
JP¥3,525.00-1.1%143.9%JP¥221.6bJP¥4,666.6729.625.5%0.6%Retail
6787
JP¥24,770.00-4.0%261.6%JP¥691.2bJP¥28,400.0032.127.6%0.6%Tech
Page 1 of 42